• AstraZeneca Settles Nexium, Prilosec Product Liability Litigations; To Pay $425 Mln

    Source: NASDAQ US Markets / 03 Oct 2023 02:04:52   America/Chicago

    (RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The specific terms of the agreements are confidential. https://www.nasdaq.com/articles/astrazeneca-settles-nexium-prilosec-product-liability-litigations-to-pay-$425-mln
Share on,